The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(1S,2S)-N-(4-(2-propionamidopropan-2-yl)phenyl)-2-(pyridin-3-yl)cyclopropane-1-carboxamide ID: ALA4210883
PubChem CID: 145966402
Max Phase: Preclinical
Molecular Formula: C21H25N3O2
Molecular Weight: 351.45
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CCC(=O)NC(C)(C)c1ccc(NC(=O)[C@H]2C[C@@H]2c2cccnc2)cc1
Standard InChI: InChI=1S/C21H25N3O2/c1-4-19(25)24-21(2,3)15-7-9-16(10-8-15)23-20(26)18-12-17(18)14-6-5-11-22-13-14/h5-11,13,17-18H,4,12H2,1-3H3,(H,23,26)(H,24,25)/t17-,18+/m1/s1
Standard InChI Key: SHWIQILHHRBUFQ-MSOLQXFVSA-N
Molfile:
RDKit 2D
28 30 0 0 0 0 0 0 0 0999 V2000
7.6684 -26.5009 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.0811 -27.2108 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.4895 -26.4984 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.9850 -28.8823 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.9838 -29.7060 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.6960 -30.1149 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.4098 -29.7055 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4070 -28.8787 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.6942 -28.4693 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5409 -28.4580 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2543 -28.8680 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.5379 -27.6367 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.9646 -28.4527 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.6698 -28.8645 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.3797 -28.4498 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.3770 -27.6276 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.6587 -27.2218 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9559 -27.6347 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1163 -28.4648 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8306 -28.8734 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8273 -28.0505 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8259 -29.6872 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0
3.1119 -27.6442 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0
8.7924 -27.6186 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.4975 -27.2055 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.2078 -27.6097 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.4923 -26.3884 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
10.2130 -28.4268 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 2 1 0
4 5 2 0
5 6 1 0
6 7 2 0
7 8 1 0
8 9 2 0
9 4 1 0
8 19 1 0
20 10 1 0
10 11 1 0
10 12 2 0
11 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 13 1 0
20 19 1 0
20 21 1 0
19 21 1 0
20 22 1 1
19 23 1 6
16 2 1 0
2 24 1 0
24 25 1 0
25 26 1 0
25 27 2 0
26 28 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 351.45Molecular Weight (Monoisotopic): 351.1947AlogP: 3.59#Rotatable Bonds: 6Polar Surface Area: 71.09Molecular Species: NEUTRALHBA: 3HBD: 2#RO5 Violations: ┄HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 13.66CX Basic pKa: 4.90CX LogP: 2.54CX LogD: 2.53Aromatic Rings: 2Heavy Atoms: 26QED Weighted: 0.84Np Likeness Score: -1.44
References 1. Palacios DS, Meredith E, Kawanami T, Adams C, Chen X, Darsigny V, Geno E, Palermo M, Baird D, Boynton G, Busby SA, George EL, Guy C, Hewett J, Tierney L, Thigale S, Weihofen W, Wang L, White N, Yin M, Argikar UA.. (2018) Structure based design of nicotinamide phosphoribosyltransferase (NAMPT) inhibitors from a phenotypic screen., 28 (3): [PMID:29275937 ] [10.1016/j.bmcl.2017.12.037 ]